A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/10/2002	US20020147159 Sustained release; antidiabetic agents
10/10/2002	US20020147156 Cellular uptake of bioactive agents
10/10/2002	US20020147150 Sustained-release preparation
10/10/2002	US20020147137 Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid
10/10/2002	US20020147131 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue
10/10/2002	US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002	US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002	US20020146786 Bacillus natto culture extract
10/10/2002	US20020146696 Dry solid medium for storage and analysis of genetic material
10/10/2002	US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002	US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002	US20020146464 Mixing a chloride hydrargyrum material and a gypsum material and pork into particles, and frying particles into pills
10/10/2002	US20020146461 Combining phase comprising wherein active agent, polymer, solvent and second phase; flowing emulsion through static mixers; combining outflow with extraction liquid for extracting solvent from emulsion to form microparticles
10/10/2002	US20020146460 Injecting into a patientaqueous suspension of solid particles suitable for intravenous delivery, the solid particles comprising a camptothecin, and a 0.3 nm to 3.0 mu m thick layer of a membrane-forming amphipathic lipid
10/10/2002	US20020146459 Dissolving biocompatible biodegradable polymer in water-immiscible solvent to yield organic phase; dissolving polyanionic bioactive agent in water; emulsification; dissolving condensing agent in water; emulsification; removing
10/10/2002	US20020146458 Scleral plug containing drug of protein derivatives
10/10/2002	US20020146457 Preparing phase comprising a polymer, a psychotherapeutic agent, and solvent; preparing an aqueous phase and combining with first pahse to form emulsion; separation; reducing solvent in discontinuous phase
10/10/2002	US20020146456 Preparation of microparticles having improved flowability
10/10/2002	US20020146455 Shelf-life; caking and sedimentation are inhibited
10/10/2002	US20020146454 Active compound is prepared in aqueous solution/ suspension; sprayed onto neutral excipients, without isolating active compound as solid substance, and dried in parallel with this, or, mixing with binder granulating with excipients and drying
10/10/2002	US20020146453 For sustained release; therapy
10/10/2002	US20020146451 Method for the administration of acid-labile drugs
10/10/2002	US20020146450 Liposome-entrapped topoisomerase inhibitors
10/10/2002	US20020146449 Compositions and methods for the targeted delivery of agents to treat liver cancer
10/10/2002	US20020146448 B-glucans encapsulated in liposomes
10/10/2002	US20020146447 Novel liposome vectors of active principles
10/10/2002	US20020146445 For percutaneous drug administration; does not irritate skin
10/10/2002	US20020146443 Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
10/10/2002	US20020146440 Reduces the healing and recovery time of skin that has been damaged
10/10/2002	US20020146437 Beauty method
10/10/2002	US20020146403 Method for the treatment of bacterial eye infections
10/10/2002	US20020146402 Method for the treatment of bacterial vaginal infections
10/10/2002	US20020146400 For threapy of atherosclerotic cardiovascular disease
10/10/2002	US20020146386 In vivo use of water absorbent polymers
10/10/2002	US20020146384 Exhibiting constant release rate and delayed release profiles
10/10/2002	US20020146376 Cosmetic products for the reduction of sweat acidity
10/10/2002	US20020146374 For therapy of candidiasis
10/10/2002	US20020146373 Administering to the respiratory system of a patient or animal hormone aerodynamically light particles, wherein particles are delivered and deposited to patient's or animal's lungs and hormone is released in patient's or animal's blood stream
10/10/2002	US20020146372 Obtaining aerosolizable topical insulin and obtaing short-acting oral hypoglycemic agent having aduration of action shorter than long-acting oral hypoglycemic agents; utilizing insulin and ingesting oral hypoglycemic agent
10/10/2002	US20020144888 Drug delivery system which effects the controlled release of a medicinally active ingredient to a targeted site
10/10/2002	DE10117676A1 Pesticidal composition, useful for controlling fleas and ticks on animals, contains permethrin and imidacloprid, in N-methylpyrrolidone
10/10/2002	DE10117208A1 Verfahren zur Herstellung von niederviskosen, wässrigen Celluloseetherlösungen A process for preparing low-viscosity, aqueous cellulose ether solutions
10/10/2002	DE10114247A1 Antibiotikum-/Antibiotika-Polymer-Kombination Antibiotic / polymer combination
10/10/2002	DE10114178A1 Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität Zinc-free and low-zinc insulin preparations with improved stability
10/10/2002	DE10106573A1 Condensed mixture of carbon dioxide and dinitrogen monoxide gases, useful for producing cold gas or cold sprays, useful in, e.g. cosmetic or medicinal applications
10/10/2002	CA2795396A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	CA2445489A1 Metronidazole pledgets
10/10/2002	CA2443128A1 Transdermal delivery of pergolide
10/10/2002	CA2442691A1 Enteric ketoacid salts and amino acids and their use for preparing medicines
10/10/2002	CA2442533A1 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
10/10/2002	CA2442532A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002	CA2442486A1 Novel chocolate composition as delivery system for nutrients and medications
10/10/2002	CA2442370A1 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
10/10/2002	CA2442365A1 Premixed amiodarone parenteral solution and method for making the same
10/10/2002	CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002	CA2442146A1 Formulations comprising entrapped active ingredients and uses thereof
10/10/2002	CA2442103A1 Prosthetic foot with tunable performance
10/10/2002	CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	CA2441662A1 Chewing gum-containing tablet
10/10/2002	CA2437789A1 Topical composition comprising an antifungal
10/10/2002	CA2435390A1 Compositions, methods and apparatuses for singlet oxygen delivery
10/09/2002	EP1247532A1 Composition promoting lacrimal secretion
10/09/2002	EP1247529A1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs
10/09/2002	EP1247526A1 Perfusion liquid preparations for ophthalmic operations
10/09/2002	EP1247524A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
10/09/2002	EP1247522A1 Polyetherester copolymers as drug delivery matricess
10/09/2002	EP1247456A2 Palatable pharmaceutical compositions for companion animals
10/09/2002	EP1246932A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation
10/09/2002	EP1246931A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles
10/09/2002	EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002	EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002	EP1246692A1 Templating of solid particles by polymer multilayers
10/09/2002	EP1246668A1 An rapid acting freeze dired oral pharmaceutical composition for treating migraine
10/09/2002	EP1246662A1 Osmotic beneficial agent delivery system
10/09/2002	EP1246645A2 A stable immunogenic composition for frozen storage
10/09/2002	EP1246639A2 Glp-2 formulations
10/09/2002	EP1246632A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses
10/09/2002	EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002	EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002	EP1246628A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/09/2002	EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002	EP1246622A1 Novel substituted benzimidazole dosage forms and method of using same
10/09/2002	EP1246617A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
10/09/2002	EP1246615A2 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
10/09/2002	EP1246614A1 Osmotic device containing venlafaxine and an anti-psychotic agent
10/09/2002	EP1246613A1 Osmotic device within an osmotic device
10/09/2002	EP1246612A1 Osmotic device containing pseudoephedrine and an h1 antagonist
10/09/2002	EP1246611A2 Formulations of active components in the form of a solid dispersion
10/09/2002	EP1246610A2 Instant granules and process for their formulation
10/09/2002	EP1246609A2 Micronized freeze-dried particles
10/09/2002	EP1246608A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
10/09/2002	EP1246607A1 Proteoliposomes containing an integral membrane protein having one or more transmembrane domains
10/09/2002	EP1246606A2 Iron chelator delivery system
10/09/2002	EP1246605A2 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow
10/09/2002	EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002	EP1246590A1 Local prevention or amelioration of pain from surgically closed wounds
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP1115391B1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/09/2002	EP1098931B1 Polyionic hydrogels based on xanthan and chitosan for stabilising and controlled release of vitamins
10/09/2002	EP1077681B1 Pharmaceutical preparation containing levothyroxine sodium

1 ... 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 ... 2991